702 Pill - red three-sided, 9mm
Generic Name: ertugliflozin
Pill with imprint 702 is Red, Three-sided and has been identified as Steglatro 15 mg. It is supplied by Merck & Co., Inc.
Steglatro is used in the treatment of Diabetes, Type 2 and belongs to the drug class SGLT-2 inhibitors. Steglatro 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 702
Steglatro
- Generic Name
- ertugliflozin
- Imprint
- 702
- Strength
- 15 mg
- Color
- Red
- Size
- 9.00 mm
- Shape
- Three-sided
- Availability
- Prescription only
- Drug Class
- SGLT-2 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck & Co., Inc.
- National Drug Code (NDC)
- 00006-5364
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
sodium starch glycolate type A potato,
magnesium stearate,
hypromellose 2910 (6 mPa.s),
polyethylene glycol 3350,
triacetin,
titanium dioxide,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "702"
More about Steglatro (ertugliflozin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (11)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: SGLT-2 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
